These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 22831484)

  • 21. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of the biological passport: the experience of the International Cycling Union.
    Zorzoli M; Rossi F
    Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical aspects in doping control: challenges and perspectives.
    Badoud F; Guillarme D; Boccard J; Grata E; Saugy M; Rudaz S; Veuthey JL
    Forensic Sci Int; 2011 Dec; 213(1-3):49-61. PubMed ID: 21824736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers: unrealized potential in sports doping analysis.
    Teale P; Barton C; Driver PM; Kay RG
    Bioanalysis; 2009 Sep; 1(6):1103-18. PubMed ID: 21083078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio.
    Athanasiadou I; Voss S; Lyris E; Aljaber A; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2016 Nov; 8(21):2265-2279. PubMed ID: 27665839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the use of stimulants in out-of-competition sport samples.
    Boghosian T; Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the health industry in the fight against doping in sport.
    Rabin O
    Forensic Sci Int; 2011 Dec; 213(1-3):10-4. PubMed ID: 21741188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical considerations in anti-doping analysis.
    Murray TH
    Bioanalysis; 2012 Jul; 4(13):1537-9. PubMed ID: 22831469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.